Product Comparison


 

No Image

Seqirus USA Inc 70461042110
Seqirus USA Inc 70461032103
Seqirus USA Inc 33332042110
Seqirus USA Inc 70461012103
McKesson # 1154170 1183068 1183069 1183078 1183071
Description CLEANER, SWIFFER WETJET CITRUSSCENT 1.25L D/S Flucelvax® Quadrivalent 2021 - 2022 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 6 Months of Age and Above Multiple Dose Vial 5 mL Flucelvax® Quadrivalent 2021 - 2022 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 6 Months of Age and Above Prefilled Syringe 0.5 mL Afluria® Quadrivalent 2021 - 2022 Flu Vaccine 60 mcg / 0.5 mL Indicated for People 6 Months of Age and Above Multiple Dose Vial 5 mL FLUAD™ 2021 - 2022 Flu Vaccine, Adjuvanted 45 mcg / 0.5 mL Indicated For People 65 Years of Age and Above Prefilled Syringe 0.5 mL
Manufacturer # PGC-77812EA70461042110704610321033333204211070461012103
Brand  Flucelvax® Quadrivalent 2021 - 2022Flucelvax® Quadrivalent 2021 - 2022Afluria® Quadrivalent 2021 - 2022FLUAD™ 2021 - 2022
Manufacturer UNITED STATIONERS SUPPLY COSeqirus USA IncSeqirus USA IncSeqirus USA IncSeqirus USA Inc
Invoice CLEANER, SWIFFER WETJET CITRUSSCENT 1.25L D/SFLUCELVAX 2021, QUAD MDV 5ML (10DOSE/VL)FLUCELVAX 2021, QUAD SYR 0.5ML(10DOSE/BX)AFLURIA 2021, QUAD MDV 5ML (10DOSE/VL)FLUAD 2021, QUAD SYR 0.5ML 65+YEAR ADJ (10DOSE/BX)
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Application Flu VaccineFlu VaccineFlu VaccineFlu Vaccine, Adjuvanted
Container Type Multiple Dose VialPrefilled SyringeMultiple Dose VialPrefilled Syringe
Country of Origin United StatesUnited StatesUnited StatesAustraliaUnited States
Dosage Form InjectionInjectionInjectionInjection
Generic Drug Code 4958349606
NDC Number 70461042110704610321033333204211070461012103
Product Dating McKesson Acceptable Dating: we will ship >= 30 daysMcKesson Acceptable Dating: we will ship >= 30 daysMcKesson Acceptable Dating: we will ship >= 30 daysMcKesson Acceptable Dating: we will ship >= 30 days
Storage Requirements Requires RefrigerationRequires RefrigerationRequires RefrigerationRequires Refrigeration
Strength 60 mcg / 0.5 mL60 mcg / 0.5 mL60 mcg / 0.5 mL45 mcg / 0.5 mL
Type IntramuscularIntramuscularIntramuscularIntramuscular
UNSPSC Code 51201608512016085120160851201608
User Indicated For People 6 Months of Age and AboveIndicated For People 6 Months of Age and AboveIndicated For People 6 Months of Age and AboveIndicated For People 65 Years of Age and Above
Volume 5 mL0.5 mL5 mL0.5 mL
Features and Benefits
  • FLUCELVAX QUADRIVALENT is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • FLUCELVAX QUADRIVALENT is approved for use in persons 6 Months of age and older
  • FLUCELVAX QUADRIVALENT 5 mL multi-dose vial formulation contains no antibiotics
  • FLUCELVAX QUADRIVALENT is standardized according to United States Public Health Service requirements for the 2021 - 2022 influenza season and is formulated to contain a total of 60 micrograms (mcg) hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA of each of the following four influenza strains:
  • A/Idaho/07/2018 (an A/Brisbane/02/2018 (H1N1)pdm09-like virus), A/Indiana/08/2018 (an A/Kansas/14/2017 (H3N2)-like virus), B/Iowa/06/2017 (a B/Colorado/06/2017-like virus), B/Singapore/INFTT-16-0610/2016 (a B/Phuket/3073/2013-like virus)
  • FLUCELVAX QUADRIVALENT is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • FLUCELVAX Quadrivalent is approved for use in persons 6 Months of age and older
  • FLUCELVAX QUADRIVALENT 0.5 mL pre-filled syringes contain no preservative or antibiotics
  • FLUCELVAX QUADRIVALENT is standardized according to United States Public Health Service requirements for the 2021 - 2022 influenza season and is formulated to contain a total of 60 micrograms (mcg) hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA of each of the following four influenza strains:
  • A/Idaho/07/2018 (an A/Brisbane/02/2018 (H1N1)pdm09-like virus), A/Indiana/08/2018 (an A/Kansas/14/2017 (H3N2)-like virus), B/Iowa/06/2017 (a B/Colorado/06/2017-like virus), B/Singapore/INFTT-16-0610/2016 (a B/Phuket/3073/2013-like virus)
  • AFLURIA QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • AFLURIA QUADRIVALENT is approved for use in persons 6 Months and older
  • The multi-dose presentation contains thimerosal added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury
  • AFLURIA QUADRIVALENT is standardized according to USPHS requirements for the 2021 - 2022 influenza season and is formulated to contain 60 mcg hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the four influenza strains recommended for the 2020 - 2021 Northern Hemisphere influenza season:
  • A/Brisbane/02/2018 (IVR-190) (an A/Brisbane/02/2018 (H1N1)pdm09 – like virus), A/Kansas/14/2017 (X-327) (an A/Kansas/14/2017 (H3N2) – like virus), B/Maryland/15/2016 (a B/Colorado/06/2017 – like virus) and B/Phuket/3073/2013 BVR-1B (a B/Phuket/3073/2013 – like virus). A 0.25 mL dose contains 7.5 mcg HA of each of the same four influenza strains.
  • Fluad is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • FLUAD is approved for use in persons 65 years of age and older
  • Each 0.5 mL dose contains at least 15 mcg of hemagglutinin (HA) from each of the following three influenza strains recommended for the 2021 - 2022 influenza season; A/Brisbane/02/2018 IVR-190 (an A/Brisbane/02/2018 (H1N1)pdm09-like virus), A/Kansas/14/2017 X-327 (an A/Kansas/14/2017 (H3N2)-like virus), B/Maryland/15/2016 (a B/Colorado/06/2017-like virus)
  • FLUAD also contains MF59C.1 adjuvant (MF59®), a squalene based oil-in-water emulsion